Clinical Trial

Dual System Study: Transvaginal Fetal Pulse Oximetry Measurement Systems

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 22, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study is to collect and compare fetal SpO2 waveforms and reference values to inform algorithm development for signal qualification and FSpO2 calculations. Subjects are women in labor.
Trial Details
NCT Number NCT07296419
Lead Sponsor Raydiant Oximetry, Inc.
Conditions Fetal Hypoxia, Fetal Acidemia
Enrollment 15 participants
Start Date 2025-12-08
Primary Completion 2026-03 (estimated)
Study Completion 2026-04 (estimated)
Updated on ClinicalTrials.gov 2025-12-22